Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens
暂无分享,去创建一个
[1] C. Roehrborn,et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. , 2007, The Lancet. Oncology.
[2] B. Tharakan,et al. Current concepts in apoptosis: The physiological suicide program revisited , 2006, Cellular & Molecular Biology Letters.
[3] E. Messing,et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. , 2005, Urology.
[4] Anirban P. Mitra,et al. Molecular staging of bladder cancer , 2005, BJU international.
[5] K. Williamson,et al. Apoptosis and chemotherapy for bladder cancer. , 2005, The Journal of urology.
[6] I. Sesterhenn,et al. World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .
[7] Fatima S. Khwaja,et al. The p75NTR tumor suppressor induces caspase‐mediated apoptosis in bladder tumor cells , 2003, International journal of cancer.
[8] E. Blomme,et al. Comparison of immunohistochemistry for activated caspase‐3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC‐3 subcutaneous xenografts , 2003, The Journal of pathology.
[9] S. Korsmeyer,et al. c-Myc Functionally Cooperates with Bax To Induce Apoptosis , 2002, Molecular and Cellular Biology.
[10] H. Moch,et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.
[11] S. Akiba,et al. Relation between cyclooxygenase‐2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder , 2001, Cancer.
[12] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[13] Colin Adrain,et al. Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis* , 2001, The Journal of Biological Chemistry.
[14] S. Diaz-Cano,et al. Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications , 2001, Virchows Archiv.
[15] T. Ebert,et al. p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer , 2000, European Urology.
[16] C. Anderson,et al. Caspase 3 and p27 as predictors of invasive bladder cancer. , 2000, The New England journal of medicine.
[17] J C Reed,et al. Mechanisms of apoptosis. , 2000, The American journal of pathology.
[18] P. Korkolopoulou,et al. Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA: relation to cell cycle regulators and survival. , 2000, Urology.
[19] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[20] V. Cryns,et al. Proteases to die for. , 1998, Genes & development.
[21] S. Nagata,et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.
[22] L. Howell,et al. Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder. , 1996, The Journal of urology.
[23] F. Waldman,et al. p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer. , 1994, Human pathology.
[24] S C Chen,et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. , 1994, The New England journal of medicine.
[25] P. Lipponen,et al. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis , 1994, The Journal of pathology.
[26] L. Marnett,et al. Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.